Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from GlaxoSmithKline ( (GSK) ) is now available.
On 26 February 2026, GSK plc repurchased 545,000 of its ordinary shares at prices between 2,155p and 2,211p, with a volume-weighted average price of 2,186.88p, under its ongoing share buyback programme executed via BNP Paribas SA. The shares, which will be held as treasury stock, lift total purchases since 17 February 2026 to 3,706,000 shares and leave GSK with 4,072,555,332 voting shares in issue and 5.98% of its voting rights now held in treasury, information that helps investors assess dilution, voting power and the scale of the company’s capital return activity.
The most recent analyst rating on (GSK) stock is a Hold with a $70.00 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GSK Stock Forecast page.
Spark’s Take on GSK Stock
According to Spark, TipRanks’ AI Analyst, GSK is a Neutral.
The score is supported primarily by resilient fundamentals (strong profitability and positive cash generation) and a constructive earnings outlook with higher dividend guidance and continued specialty/HIV momentum. These positives are tempered by leverage and recent revenue/FCF volatility, while technically the stock is in a strong uptrend but looks overbought, raising near-term pullback risk.
To see Spark’s full report on GSK stock, click here.
More about GlaxoSmithKline
GSK plc is a global biopharmaceutical company headquartered in London, focusing on the research, development and commercialization of vaccines, specialty medicines and consumer healthcare products. The group targets major therapeutic areas including infectious diseases, respiratory conditions and oncology, and is a significant constituent of U.K. and international equity indices, making its capital allocation policies closely watched by institutional investors.
Average Trading Volume: 4,919,155
Technical Sentiment Signal: Buy
Current Market Cap: $120.5B
See more data about GSK stock on TipRanks’ Stock Analysis page.